Annual Working Capital
$94.06 M
+$2.13 M+2.32%
31 December 2023
Summary:
Spero Therapeutics annual working capital is currently $94.06 million, with the most recent change of +$2.13 million (+2.32%) on 31 December 2023. During the last 3 years, it has fallen by -$45.15 million (-32.43%). SPRO annual working capital is now -32.43% below its all-time high of $139.20 million, reached on 31 December 2021.SPRO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$82.53 M
+$5.95 M+7.76%
30 September 2024
Summary:
Spero Therapeutics quarterly working capital is currently $82.53 million, with the most recent change of +$5.95 million (+7.76%) on 30 September 2024. Over the past year, it has dropped by -$11.52 million (-12.25%). SPRO quarterly working capital is now -40.71% below its all-time high of $139.20 million, reached on 31 December 2021.SPRO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPRO Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -12.3% |
| 3 y3 years | -32.4% | -40.7% |
| 5 y5 years | +36.8% | +20.0% |
SPRO Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -32.4% | +2.3% | -40.7% | +125.1% |
| 5 y | 5 years | -32.4% | +36.8% | -40.7% | +125.1% |
| alltime | all time | -32.4% | >+9999.0% | -40.7% | +1566.0% |
Spero Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $82.53 M(+7.8%) |
| June 2024 | - | $76.58 M(-22.1%) |
| Mar 2024 | - | $98.33 M(+4.5%) |
| Dec 2023 | $94.06 M(+2.3%) | $94.06 M(+22.5%) |
| Sept 2023 | - | $76.76 M(+8.1%) |
| June 2023 | - | $71.03 M(-9.7%) |
| Mar 2023 | - | $78.67 M(-14.4%) |
| Dec 2022 | $91.92 M(-34.0%) | $91.92 M(+150.7%) |
| Sept 2022 | - | $36.66 M(-2.8%) |
| June 2022 | - | $37.73 M(-40.6%) |
| Mar 2022 | - | $63.51 M(-54.4%) |
| Dec 2021 | $139.20 M(+11.5%) | $139.20 M(+21.6%) |
| Sept 2021 | - | $114.51 M(+22.5%) |
| June 2021 | - | $93.49 M(-16.3%) |
| Mar 2021 | - | $111.73 M(-10.5%) |
| Dec 2020 | $124.80 M | $124.80 M(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $125.11 M(+88.8%) |
| June 2020 | - | $66.27 M(-11.9%) |
| Mar 2020 | - | $75.22 M(+9.4%) |
| Dec 2019 | $68.75 M(-38.6%) | $68.75 M(-22.7%) |
| Sept 2019 | - | $88.91 M(-14.9%) |
| June 2019 | - | $104.44 M(-4.3%) |
| Mar 2019 | - | $109.08 M(-2.5%) |
| Dec 2018 | $111.90 M(+33.4%) | $111.90 M(-9.4%) |
| Sept 2018 | - | $123.44 M(+93.2%) |
| June 2018 | - | $63.89 M(-13.5%) |
| Mar 2018 | - | $73.90 M(-11.9%) |
| Dec 2017 | $83.90 M(+1593.6%) | $83.90 M(+317.7%) |
| Sept 2017 | - | $20.09 M(-35.3%) |
| June 2017 | - | $31.06 M(+527.0%) |
| Dec 2016 | $4.95 M(-1244.1%) | $4.95 M |
| Dec 2015 | -$433.00 K | - |
FAQ
- What is Spero Therapeutics annual working capital?
- What is the all time high annual working capital for Spero Therapeutics?
- What is Spero Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Spero Therapeutics?
- What is Spero Therapeutics quarterly working capital year-on-year change?
What is Spero Therapeutics annual working capital?
The current annual working capital of SPRO is $94.06 M
What is the all time high annual working capital for Spero Therapeutics?
Spero Therapeutics all-time high annual working capital is $139.20 M
What is Spero Therapeutics quarterly working capital?
The current quarterly working capital of SPRO is $82.53 M
What is the all time high quarterly working capital for Spero Therapeutics?
Spero Therapeutics all-time high quarterly working capital is $139.20 M
What is Spero Therapeutics quarterly working capital year-on-year change?
Over the past year, SPRO quarterly working capital has changed by -$11.52 M (-12.25%)